itinai content

  • AI News
  • AI Sales
  • Apple AI
  • Biohacking
  • Clinical Trials
  • Compare
  • Computer Vision
  • DeepSense
  • farma
  • Instruments
  • Management
  • Marketing
  • Marktechpost
  • Open AI
  • resume
  • КП
  • Building Innovation Teams Across National Borders

    10 сентября, 2025

    Chris Gash The Research The authors studied the impact of the 2004 H-1B visa cap reduction on 707 U.S.-based multinational enterprises, analyzing how immigration restrictions affected the geographic dispersion of inventor teams and innovation outcomes. Key findings include a 4.7% increase in geographic dispersion of inventors following the cap reduction and corresponding decreases of 4.15%… →

    Management
  • A Data-Driven Approach to Advancing Meritocracy

    10 сентября, 2025

    Chris Gash Building meritocratic and equitable organizations is a complex yet critical endeavor, as many corporate leaders have come to realize. It requires effective talent management systems to attract, develop, and retain qualified and motivated individuals — key drivers of organizational success. In my book, The Meritocracy Paradox, I caution that certain organizational efforts to… →

    Management
  • How to Foster Talent Management Champions

    10 сентября, 2025

    Chris Gash The Research To explore how middle managers navigate talent management, the authors conducted a qualitative study in which they collected data through 147 semistructured in-depth interviews across 26 multinational organizations. The interviews focused on how the organizations identified, developed, retained, and deployed talent; the role of middle managers; and challenges in executing talent… →

    Management
  • GTM 162: From PLG to Enterprise: How to Layer Sales Without Breaking What Works | Ghazi Masood

    10 сентября, 2025

    The GTM Podcast is available on any major directory, including: Apple Podcasts Spotify YouTube Ghazi Masood is the Chief Revenue Officer at Retool, where he leads the go-to-market engine for the low-code developer platform. Previously he served as SVP & GM, Americas at Auth0 after leadership roles at Microsoft, Oracle, Polycom, and Nintex K2, and… →

    AI Sales
  • The GTM Newsletter is now GTMnow, and we’re live on Product Hunt

    10 сентября, 2025

    When we first launched The GTM Newsletter, our goal was simple: give founders and GTM leaders practical insights you could actually use. Since then, thousands of you have subscribed, and our community has grown to over 50,000 founders, GTM leaders, and investors. Along the way, one thing became clear: this was becoming more than a… →

    AI Sales
  • Digital Psychological Intervention for Inflammatory Rheumatic Diseases: A Pilot Randomized Clinical Trial

    9 сентября, 2025

    CONCLUSIONS AND RELEVANCE: This pilot randomized clinical trial supports the effectiveness and safety of a digital psychological intervention in individuals with IRDs. These findings suggest that such digital interventions could be a valuable, scalable approach to addressing mental health needs in rheumatology. →

    Clinical Trials
  • Randomized Clinical Trial on the Efficacy of Oral Tranexamic Acid Versus Topical Tranexamic Acid in Treatment of Melasma

    9 сентября, 2025

    CONCLUSION: Both forms of TXA are effective with low side effects. The choice between oral and topical TXA can depend on patient preference and convenience. →

    Clinical Trials
  • In-the-Bag Behavior of a New Aspheric Hydrophobic Acrylic Toric Intraocular Lens

    9 сентября, 2025

    CONCLUSIONS: Tilt and decentration of the Clareon TIOL were generally low and a strong correlation was found between crystalline lens tilt and TIOL tilt at 6 months. →

    Clinical Trials
  • MBZUAI Researchers Release K2 Think: A 32B Open-Source System for Advanced AI Reasoning and Outperforms 20X Larger Reasoning Models

    9 сентября, 2025

    «`html Understanding the Target Audience for K2 Think The target audience for K2 Think primarily includes AI researchers, data scientists, and business managers focused on utilizing advanced AI systems for specific applications. These individuals are typically associated with academic institutions, research organizations, or enterprises that invest in AI technologies. Pain Points Complexity of existing AI… →

    AI News
  • Efficacy of Facial Botulinum Toxin A Injections in Alleviating Neuropsychiatric Symptoms in Parkinson’s Disease Patients: An Open-Label, Nonrandomized Controlled Trial

    9 сентября, 2025

    CONCLUSIONS: In summary, BTX-A demonstrates efficacy in reducing multiple neuropsychiatric symptoms (such as tension, anxiety, depression, sensitivity, etc.) in PD, with comparable effectiveness to CH, supporting its consideration as an alternative therapeutic option. →

    Clinical Trials
Предыдущая страница
1 … 3 4 5 6 7 … 783
Следующая страница